Welcome to LookChem.com Sign In|Join Free

CAS

  • or

78326-88-2

Post Buying Request

78326-88-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

78326-88-2 Usage

General Description

5-(benzyloxy)-2,3-dihydroinden-1-one is a chemical compound with the formula C20H18O2. It is a white to off-white crystalline powder that is insoluble in water but soluble in organic solvents. The compound is commonly used in organic synthesis and chemical research as a building block for the production of various pharmaceuticals and fine chemicals. It is also a potential precursor for the synthesis of various biologically active compounds. The compound is known for its aromatic properties and is commonly used in the pharmaceutical and chemical industries for its versatile applications.

Check Digit Verification of cas no

The CAS Registry Mumber 78326-88-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,3,2 and 6 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 78326-88:
(7*7)+(6*8)+(5*3)+(4*2)+(3*6)+(2*8)+(1*8)=162
162 % 10 = 2
So 78326-88-2 is a valid CAS Registry Number.

78326-88-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-phenylmethoxy-2,3-dihydroinden-1-one

1.2 Other means of identification

Product number -
Other names 5-benzyloxy-indan-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:78326-88-2 SDS

78326-88-2Relevant articles and documents

Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson’s Disease

Hagenow, Stefanie,Affini, Anna,Pioli, Elsa Y.,Hinz, Sonja,Zhao, Yan,Porras, Gregory,Namasivayam, Vigneshwaran,Müller, Christa E.,Lin, Jian-Sheng,Bezard, Erwan,Stark, Holger

supporting information, p. 8246 - 8262 (2021/06/30)

Adenosine A1/A2Areceptors (A1R/A2AR) represent targets in nondopaminergic treatment of motor disorders such as Parkinson’s disease (PD). As an innovative strategy, multitargeting ligands (MTLs) were developed to achieve comprehensive PD therapies simultaneously addressing comorbid symptoms such as sleep disruption. Recognizing the wake-promoting capacity of histamine H3receptor (H3R) antagonists in combination with the “caffeine-like effects” of A1R/A2AR antagonists, we designed A1R/A2AR/H3R MTLs, where a piperidino-/pyrrolidino(propyloxy)phenyl H3R pharmacophore was introduced with overlap into an adenosine antagonist arylindenopyrimidine core. These MTLs showed distinct receptor binding profiles with overall nanomolar H3R affinities (Kii(A1R) = 11.5 nM,Ki(A2AR) = 7.25 nM) and 12( ST-1992,Ki(A1R) = 11.2 nM,Ki(A2AR) = 4.01 nM) were evaluatedin vivo.l-DOPA-induced dyskinesia was improved after administration of compound 4(1 mg kg-1, i.p. rats). Compound 12(2 mg kg-1, p.o. mice) increased wakefulness representing novel pharmacological tools for PD therapy.

METHODS OF DOSE ADMINISTRATION FOR TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES

-

Paragraph 0390; 0391, (2018/06/15)

The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders.

A photo-favorskii ring contraction reaction: The effect of ring size

Kammath, Viju Balachandran,?olomek, Tomá?,Ngoy, Bokolombe Pitchou,Heger, Dominik,Klán, Petr,Rubina, Marina,Givens, Richard S.

, p. 1718 - 1729 (2013/03/29)

The effect of ring size on the photo-Favorskii induced ring-contraction reaction of the hydroxybenzocycloalkanonyl acetate and mesylate esters (7a-d, 8a-c) has provided new insight into the mechanism of the rearrangement. By monotonically decreasing the ring size in these cyclic derivatives, the increasing ring strain imposed on the formation of the elusive bicyclic spirocyclopropanone 20 results in a divergence away from rearrangement and toward solvolysis. Cycloalkanones of seven or eight carbons undergo a highly efficient photo-Favorskii rearrangement with ring contraction paralleling the photochemistry of p-hydroxyphenacyl esters. In contrast, the five-carbon ring does not rearrange but is diverted to the photosolvolysis channel avoiding the increased strain energy that would accompany the formation of the spirobicyclic ketone, the "Favorskii intermediate 20". The six-carbon analogue demonstrates the bifurcation in reaction channels, yielding a solvent-sensitive mixture of both. Employing a combination of time-resolved absorption measurements, quantum yield determinations, isotopic labeling, and solvent variation studies coupled with theoretical treatment, a more comprehensive mechanistic description of the rearrangement has emerged.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 78326-88-2